Document Detail


Pacemaker therapy in patients with atrial fibrillation.
MedLine Citation:
PMID:  8094937     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pacing is indicated in patients with AF when clinical symptoms are readily attributable to slow ventricular rate and prolonged ventricular pauses. When choosing a pacemaker for implantation, one should consider the importance of a reasonable chronotropic response to exercise and provide a rate-responsive system (VVIR) for those patients who show chronotropic incompetence. In the case of paroxysmal AF, an AV synchronized system may provide protection against deterioration to chronic AF and heart failure and is preferred over VVI pacing, providing that paroxysms are infrequent. Drug-pacemaker interaction is rare, but it is recommended that class IC antiarrhythmic agents should not be used in pacemaker-dependent patients. Cardioversion should be performed with care in patients with a permanent pacemaker, and certain protective measures must be employed to avoid pacemaker destruction or malfunction. Pacemakers, when used according to strict criteria, constitute an integral part of treatment and may improve the quality of life and facilitate the use of necessary drugs in selected patients with AF.
Authors:
A Pollak; R H Falk
Related Documents :
20664267 - Prevention of stroke in patients with atrial fibrillation: the role of new antiarrhythm...
11258507 - Treatment of tuberculosis in a rural area of haiti: directly observed and non-observed ...
20643247 - Obesity and outcomes among patients with established atrial fibrillation.
17526457 - Acute coronary syndrome: short-term effects of early intravenous metoprolol on maximum ...
22555317 - Ultrasonographic measurement of the femoral cartilage thickness in hemiparetic patients...
7656937 - Elevation of tumour markers in serum and bronchoalveolar lavage fluid in pulmonary alve...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  American heart journal     Volume:  125     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  1993 Mar 
Date Detail:
Created Date:  1993-03-25     Completed Date:  1993-03-25     Revised Date:  2006-02-27    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  824-30     Citation Subset:  AIM; IM    
Affiliation:
Cardiology Section, Boston City Hospital, MA 02118.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / pharmacology
Aged
Anti-Arrhythmia Agents / pharmacology
Atrial Fibrillation / therapy*
Cardiac Pacing, Artificial / methods*
Digoxin / pharmacology
Electric Countershock
Humans
Pacemaker, Artificial*
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Anti-Arrhythmia Agents; 20830-75-5/Digoxin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pulmonary hypertension is a contraindication to beta-blockade in patients with severe mitral stenosi...
Next Document:  Comparison of computer ST criteria for diagnosis of severe coronary artery disease.